Early-Stage Obstacles Can Derail Drug Programmes
Biotech companies operate in a high stakes environment, often with limited resources and pressure to demonstrate success with short timelines.
Typical bioscience hurdles we see:
- Complex targets and novel modalities that demand specialist expertise.
- Gaps in translational models or assay development.
- Limited access to specialist assays and high-throughput technology.
- Data gaps that slow hit-to-lead progression and erode investor confidence.
- Difficulty scaling ideas into robust, reproducible processes.
- Pressure to prove biological relevance while conserving limited funds.
“The journey from novel concept to clinical candidate is fraught with risk.
Great compounds often fail to deliver early promise – not because the idea is wrong, but because the complex biology is not fully understood in time.
The right assays – and the right people – make all the difference.”
Kathy Dodgson
Technical Director at CatSci
Turning Complex Bioscience Challenges into Bespoke Solutions
-
Efficient Assay Design – Fit-for-purpose screening cascades built by expert scientists.
-
Multi-Modal Readouts – Biophysical, biochemical, cell-based, and ex vivo systems for 360° confidence.
-
Scalable Automation – Liquid handling, RT-qPCR, flow cytometry, multimodal plate readers, and live cell fluorescent imaging to accelerate data generation.
-
Quality-First Workflows – SOP-driven processes, robust controls, and transparent documentation.
-
Secure Partnership – UK-based lab with strict confidentiality protocols and encrypted data management safeguard your IP.
Bioscience at CatSci
Bespoke Drug Discovery
Our state-of-the-art facility in BioCity, Nottingham, is home to a brand-new laboratory and a team of experts with decades of combined experience.
We act as an extension of your team, providing the people, platforms, and processes you need to progress promising science with certainty.
-
Discover – Understand target biology and map data gaps.
-
Design – Craft bespoke assay cascades aligned to programme goals.
-
Execute – Run validated assays with cutting-edge automation for speed and reproducibility.
-
Interpret – Multidisciplinary experts translate raw results into clear go / no-go decisions.
-
Optimise – Iterate rapidly to refine compounds, assays, and strategy.
Bioscience Capabilities
- Throughput Boost: Automated liquid handling accelerates hit discovery and lead optimisation.
- Precision & Consistency: Accurate dispensing drives reproducible, quality-controlled robust assays.
- Adaptable Platforms: Enabling custom assay design across discovery stages.
- Multiparametric Profiling: Flow cytometry delivers rich phenotypic and biomarker data.
- Live-Cell Analysis: 96- and 384-well plate setups enable scalable screening.
